Foresight in clinical proteomics: current status, ethical considerations, and future perspectives.

Area of Science:

• Proteomics
• Clinical Research
• Bioinformatics

Background:

• Proteomics technologies and bioinformatics tools enable large-scale data analysis in life sciences.
• Proteins are key targets for over 95% of FDA-approved drugs and most diagnostic tests.

Discussion:

• Leaders convened at the CTLS conference, discussing the clinical implementation of proteomics.
• Key topics included the current status, challenges, and future directions for clinical proteomics.

Key Insights:

• Clinical proteomics is emerging for patient stratification and treatment guidance.
• Ethical considerations are paramount for handling large-scale clinical proteomics data.

Outlook:

• Recommendations are provided for the ethical and effective implementation of clinical proteomics.
• Efforts are needed to establish proteomics as a mainstream technology in translational and clinical research.